Drugs / insulin neutral protamine Hagedorn
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01837680 | Mar 2013 → Mar 2015 | gestational diabetes, type 2 diabetes mellitus | St. Luke's-Roosevelt Hospital Center | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | insulin neutral protamine Hagedorn | “OBJECTIVE: We sought to determine if insulin detemir (IDet) is noninferior to insulin neutral protamine Hagedorn (NPH) for the treatment of gestational diabetes mellitus (GDM)...” PMID 26070699 ↗ Jun 2015 |
| Known as | NPH | “OBJECTIVE: We sought to determine if insulin detemir (IDet) is noninferior to insulin neutral protamine Hagedorn (NPH) for the treatment of gestational diabetes mellitus (GDM)...” PMID 26070699 ↗ Jun 2015 |